Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
S | Common Stock | D | 15000 | $18.19 - $18.19 | $272,871 |
| 2024-04-15 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
M | Common Stock | A | 15000 | $3.76 - $3.76 | $56,400 |
| 2024-03-19 | REGENXBIO Inc. | Vasista Vittal
(Chief Financial Officer) |
M | Common Stock | A | 20041 | $3.76 - $3.76 | $75,354 |
| 2024-03-14 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
S | Common Stock | D | 15000 | $21.86 - $21.86 | $327,942 |
| 2024-03-14 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
M | Common Stock | A | 15000 | $3.76 - $3.76 | $56,400 |
| 2024-03-05 | REGENXBIO Inc. | PAKOLA STEVE
(Chief Medical Officer) |
S | Common Stock | D | 12878 | $28.36 - $28.36 | $365,220 |
| 2024-03-05 | REGENXBIO Inc. | PAKOLA STEVE
(Chief Medical Officer) |
M | Common Stock | A | 12878 | $22.25 - $22.25 | $286,535 |
| 2024-02-14 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
S | Common Stock | D | 15000 | $16.47 - $16.88 | $251,347 |
| 2024-02-14 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
M | Common Stock | A | 15000 | $3.76 - $3.76 | $56,400 |
| 2024-01-16 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
S | Common Stock | D | 45000 | $15.18 - $15.18 | $682,992 |
| 2024-01-16 | REGENXBIO Inc. | Mills Kenneth T.
(President and CEO) |
M | Common Stock | A | 45000 | $3.76 - $3.76 | $169,200 |
| 2024-01-03 | REGENXBIO Inc. | PAKOLA STEVE
(Chief Medical Officer) |
S | Common Stock | D | 17237 | $17.39 - $17.39 | $299,789 |
| 2024-01-02 | REGENXBIO Inc. | Vasista Vittal
(Chief Financial Officer) |
F | Common Stock | D | 4534 | $17.95 - $17.95 | $81,385 |
| 2024-01-02 | REGENXBIO Inc. | Vasista Vittal
(Chief Financial Officer) |
A | Common Stock | A | 16026 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |